» Articles » PMID: 12457224

Rat C6 Glioma As Experimental Model System for the Study of Glioblastoma Growth and Invasion

Overview
Journal Cell Tissue Res
Date 2002 Nov 29
PMID 12457224
Citations 137
Authors
Affiliations
Soon will be listed here.
Abstract

Infiltration of the central nervous system by neoplastic cells in patients with glioblastoma multiforme (GBM) leads to neurological dysfunction and eventually to death. The elucidation of the mechanisms underlying the aggressive nature of GBM aims at improving radio-, chemo- and gene therapy. This review is focused on the use of rat C6 glioma as an experimental model system for GBM and provides an overview of the experimental data published in the literature using this cell line in elucidating the mechanism of tumor growth, angiogenesis and invasion, and in the design and evaluation of anticancer therapies. Understanding the stages of malignant brain tumor progression requires a series of experimental approaches with a varying degree of complexity. Implantation of malignant cells into animal brain tissue closely resembles in vivo tumor growth and has the advantage over simplified models that inflammatory and vascular mechanisms are activated. However, the complexity of these models makes it difficult to identify the individual processes involved in sustained tumor growth, angiogenesis and invasion. In cell culture models, the effect of growth factors, extracellular matrix components, proteases and adhesion molecules can be investigated. The secretion of tumor-derived factors into the medium can also be analyzed when simplified models are used. This review is a compilation of experimental data focused on the characterization of tumor-related processes and on the evaluation of new therapies for the treatment of malignant glial neoplasms using rat C6 glioma as a model system.

Citing Articles

Amelioration of Astrocytic Dysfunction via AQP4/LRP1 Pathway by and Tricin in C6 Cells Exposed to Amyloid β and High-Dose Insulin and in Mice Treated with Scopolamine.

Yang S, Park S, Kim E, Bae W, Jhee K J Microbiol Biotechnol. 2025; 35:e2412026.

PMID: 40016145 PMC: 11896795. DOI: 10.4014/jmb.2412.12026.


Enpp1 ameliorates MAFLD by regulating hepatocyte lipid metabolism through the AMPK/PPARα signaling pathway.

Liu X, Chen S, Liu X, Wu X, Jiang X, Li Y Cell Biosci. 2025; 15(1):22.

PMID: 39972484 PMC: 11841222. DOI: 10.1186/s13578-025-01364-3.


Transcranial Magnetic Stimulation Enhances the Therapeutic Effect of IGF-Trap in Intracerebral Glioma Models.

Perrino S, Vazana U, Prager O, Schori L, Ben-Arie G, Minarik A Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770449 PMC: 11677529. DOI: 10.3390/ph17121607.


Combined machine learning models, docking analysis, ADMET studies and molecular dynamics simulations for the design of novel FAK inhibitors against glioblastoma.

Zhao Y, He X, Wan Q BMC Chem. 2024; 18(1):203.

PMID: 39425154 PMC: 11490052. DOI: 10.1186/s13065-024-01316-x.


Combination chemotherapy via poloxamer 188 surface-modified PLGA nanoparticles that traverse the blood-brain-barrier in a glioblastoma model.

Madani F, Morovvati H, Webster T, Najaf Asaadi S, Rezayat S, Hadjighassem M Sci Rep. 2024; 14(1):19516.

PMID: 39174603 PMC: 11341868. DOI: 10.1038/s41598-024-69888-1.